Reply to Gaipa et Al.
van der Sluijs-Gelling
A J
AJ
van der Velden
V H J
VH
Roeffen
E T J M
ET
Veerman
A J P
AJ
van Wering
E R
ER
D000951:Antigens, Neoplasm / Q000032:analysis*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002051:Burkitt Lymphoma / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D049109:Cell Proliferation / Q000187:drug effects; D002648:Child; D006801:Humans; D016130:Immunophenotyping; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor